80 likes | 93 Views
According to a new market research study titled u2018Vaccines Market - Global Analysis and Forecasts by Technology, Disease Indication, Route of Administration, and Patient Type. The global vaccines market is expected to reach US$ 64,538.4 Mn in 2027 from US$ 36,998.8 in 2018. The market is estimated to grow with a CAGR of 6.5% from 2019-2027. The report highlights the trends prevalent in the global vaccines market and the factors driving the market along with those that act as deterrents to its growth.<br>Get Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00003424/ <br>The vaccines market b
E N D
Vaccines Market Global Analysis and Forecast to 2028 Email: sales@theinsightpartners.com
Email: sales@theinsightpartners.com Report Studies Vaccines Market to 2027- Global Analysis and Forecasts by Technology (Recombinant Vaccines, Conjugate Vaccines, Live Attenuated Vaccines, Inactivated and Subunit Vaccines, and Toxoid Vaccines); Disease Indication (DTP (Diphtheria Tetanus toxoids and Pertussis), Influenza, Hepatitis, Respiratory Syncytial Virus (RSV), and Other Diseases); Route of Administration (Oral, Injectable, and Other Routes of Administration); Patient Type (Pediatric Patients, and Adult Patients) and Geography 2
Email: sales@theinsightpartners.com Vaccines Market Overview The global vaccines market is expected to reach US$ 64,538.4 Mn in 2027 from US$ 36,998.8 Mn in 2018. The market is estimated to grow with a CAGR of 6.5% from 2019- 2027. The vaccines market by technology is segmented into Recombinant vaccines, Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, and Toxoid Vaccines. In 2018, the conjugate vaccines segment held a largest market share of 65.1% of the vaccines market, By Technology. This segment is also expected to dominate the market in 2027 3
Email: sales@theinsightpartners.com Key Segment Market Segment :- by Technology (Recombinant Vaccines, Conjugate Vaccines, Live Attenuated Vaccines, Inactivated and Subunit Vaccines, and Toxoid Vaccines) Disease Indication (DTP (Diphtheria Tetanus toxoids and Pertussis), Influenza, Hepatitis, Respiratory Syncytial Virus (RSV), and Other Diseases) Route of Administration (Oral, Injectable, and Other Routes of Administration) Patient Type (Pediatric Patients, and Adult Patients) and Geography 4
Email: sales@theinsightpartners.com $50,000 Vaccines Market Value $40,000 $30,000 CAGR of 6.5% $20,000 (2020-2027) $10,000 $0 20XX 20XX 20XX 20XX 20XX Download Sample 5
Email: sales@theinsightpartners.com Company Profiles PFIZER INC GlaxoSmithKline plc. Merck & Co., Inc. Sanofi Johnson & Johnson Services, Inc Panacea Biotec Limited Astellas Pharma Inc. NOVAVAX, INC. VBI Vaccines Inc. Bavarian Nordic 6 Download Sample Here
Email: sales@theinsightpartners.com By Geography North America (the US, Canada, and Mexico) Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe) Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific) Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa) South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7
THANK YOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com